ConductScience.org, home

Paper39765794

Synergistic ROS Reduction Through the Co-Inhibition of BRAF and p38 MAPK Ameliorates Senescence.

Kuk MU and 10 others. Antioxidants (Basel), 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Synergistic ROS Reduction Through the Co-Inhibition of BRAF and p38 MAPK Ameliorates Senescence. Papers, record 39765794. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39765794

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synergistic ROS Reduction Through the Co-Inhibition of BRAF and p38 MAPK Ameliorates Senescence.
PubMed
Journal
Antioxidants (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.9, provisional
iCite
Revised in PubMed
2025-01-08
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kuk MUMyeong Uk
2Kim DDuyeol
3Lee YHYun Haeng
4Yoon JHJee Hee
5Park JHJi Ho
6Lee YJYoo Jin
7So BHByeong Hyeon
8Kim MMinseon
9Kwon HWHyung Wookhttps://orcid.org/0000-0001-9340-7974
10Byun YYoungjoohttps://orcid.org/0000-0002-0297-7734
11Park JTJoon Taehttps://orcid.org/0000-0003-2396-9108

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
HP23C0024Ministry of Health & Welfare, Republic of KoreaPubMed

Source PubMed

Download CSV of grants

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129477613Hallmarks of Cellular Senescence.Trends Cell Biol2018https://conductscience.org/library/papers/29477613PubMed
239073681A Senomorphlytic Three-Drug Combination Discovered in Salsola collina for Delaying Aging Phenotypes and Extending Healthspan.Adv Sci (Weinh)2024https://conductscience.org/library/papers/39073681PubMed
336978899Aging Hallmarks and the Role of Oxidative Stress.Antioxidants (Basel)2023https://conductscience.org/library/papers/36978899PubMed
424752504PARP-1 hyperactivation and reciprocal elevations in intracellular Ca2+ during ROS-induced nonapoptotic cell death.Toxicol Sci2014https://conductscience.org/library/papers/24752504PubMed
532997601Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.Annu Rev Pharmacol Toxicol2021https://conductscience.org/library/papers/32997601PubMed
636657533Functional restoration of lysosomes and mitochondria through modulation of AKT activity ameliorates senescence.Exp Gerontol2023https://conductscience.org/library/papers/36657533PubMed
733260892BRAF: A Two-Faced Janus.Cells2020https://conductscience.org/library/papers/33260892PubMed
824360282Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging.Cell2013https://conductscience.org/library/papers/24360282PubMed
922025288Cellular senescence and tumor suppressor gene p16.Int J Cancer2012https://conductscience.org/library/papers/22025288PubMed
1033028824NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.Signal Transduct Target Ther2020https://conductscience.org/library/papers/33028824PubMed
1131115493Mitochondrial electron transport chain, ROS generation and uncoupling (Review).Int J Mol Med2019https://conductscience.org/library/papers/31115493PubMed
1237107309Targeting Mitochondrial Oxidative Stress as a Strategy to Treat Aging and Age-Related Diseases.Antioxidants (Basel)2023https://conductscience.org/library/papers/37107309PubMed
1338831382Role of cellular senescence in inflammation and regeneration.Inflamm Regen2024https://conductscience.org/library/papers/38831382PubMed
1436919762Metabolic shift towards oxidative phosphorylation reduces cell-density-induced cancer-stem-cell-like characteristics in prostate cancer in vitro.Biol Open2023https://conductscience.org/library/papers/36919762PubMed
1531675495Cellular Senescence: Defining a Path Forward.Cell2019https://conductscience.org/library/papers/31675495PubMed
1635378718Glycolytic and Oxidative Phosphorylation Defects Precede the Development of Senescence in Primary Human Brain Microvascular Endothelial Cells.Geroscience2022https://conductscience.org/library/papers/35378718PubMed
1726050973Mitochondrial dysfunction in aging: Much progress but many unresolved questions.Biochim Biophys Acta2015https://conductscience.org/library/papers/26050973PubMed
1827518619Mitochondrial Membrane Potential Assay.Methods Mol Biol2016https://conductscience.org/library/papers/27518619PubMed
1923967274Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice.PLoS One2013https://conductscience.org/library/papers/23967274PubMed
201962047Mitochondria: structure and function.Rev Neurol (Paris)1991https://conductscience.org/library/papers/1962047PubMed

See all 67 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42439653Orchestration of Autophagy and Senescence: Kinases Take the Center Stage.Cells2026https://conductscience.org/library/papers/42439653PubMed
41915085Cancer and aging: complex associations and therapeutic targets.Mol Biomed2026https://conductscience.org/library/papers/41915085PubMed
41858782Lens epithelial cells senescence in cataract pathogenesis and emerging therapeutic opportunities.Front Cell Dev Biol2026https://conductscience.org/library/papers/41858782PubMed
41250171CBX7 regulates chemotherapy-induced senescence-like growth arrest in multiple myeloma via the ERK/STAT3/PIM1 axis.J Transl Med2025https://conductscience.org/library/papers/41250171PubMed
40338239Berberine Extends Lifespan in C. elegans Through Multi-Target Synergistic Antioxidant Effects.Antioxidants (Basel)2025https://conductscience.org/library/papers/40338239PubMed
40227233Sauchinone Ameliorates Senescence Through Reducing Mitochondrial ROS Production.Antioxidants (Basel)2025https://conductscience.org/library/papers/40227233PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
MT2A4502PubTator's text mininghttps://conductscience.org/library/genes/4502NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39765794

GET https://conductscience.org/api/papers/v1/39765794/references?page=2